Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/10600

Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis


Thumbnail

See/Open:
 Assessment_Vilar_BMCVR_2014.pdf
399,18 kB
Adobe PDF
Title: Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis
Authors : Vilar, José M.
Batista, Miguel
Morales, Manuel
Santana, Angelo
Cuervo Serrato, Belén
Rubio Zaragoza, Mónica.
Cugat Bertomeu, Ramón
Sopena Juncosa, Joaquín Jesús.
Carrillo Poveda, José María.
Keywords: Células madre - Uso terapéutico.Stem cells - Therapeutic use.Osteoartritis en los perros.Growth factors - Therapeutic use.Cojera en los perros.Lameness in dogs.Crecimiento - Factores - Uso terapéutico.Osteoarthritis in dogs.
Publisher: BioMed Central.
Citation: Vilar, JM., Batista, M., Morales, M., Santana, A., Cuervo, B., Rubio, M. et al. (2014). Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis. BMC Veterinary Research, vol. 10 (1 jul. 2014), art. 143. DOI: https://doi.org/10.1186/1746-6148-10-143
Abstract: Background: Regenerative medicine using Mesenchymal Stem Cells (MSC) alone or combined with Plasma Rich in Growth Factors (PRGF) is a rapidly growing area of clinical research and is currently also being used to treat osteoarthritis (OA). Force platform analysis has been consistently used to verify and quantify the efficacy of different therapeutic strategies for the treatment of OA in dogs including MSC associated to PRGF, but never with AD-MSC alone. The aim of this study was to use a force platform to measure the efficacy of intraarticular ADMSC administration for limb function improvement in dogs with severe OA. Results: Ten lame dogs with severe hip OA and a control group of 5 sound dogs were used for this study. Results were statistically analyzed to detect a significant increase in peak vertical force (PVF) and vertical impulse (VI) in treated dogs. Mean values of PVF and VI were significantly improved within the first three months post-treatment in the OA group, increasing 9% and 2.5% body weight, respectively, at day 30. After this, the effect seems to decrease reaching initial values. Conclusion: Intraarticular ADMSC therapy objectively improved limb function in dogs with hip OA. The duration of maximal effect was less than 3 months.
Description: Este artículo se encuentra disponible en la siguiente URL: https://bmcvetres.biomedcentral.com/articles/10.1186/1746-6148-10-143
URI: http://hdl.handle.net/10637/10600
Rights : http://creativecommons.org/licenses/by/4.0/deed.es
ISSN: 1746-6148
1746-6148 (Electrónico)
Issue Date: 1-Jul-2014
Center : Universidad Cardenal Herrera-CEU
Appears in Collections:Dpto. Medicina y Cirugía Animal





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.